| Ident. | Authors (with country if any) | Title |
|---|
| 000071 |
QIAOLI LI [République populaire de Chine] ; ZHENHUAN ZHAO [République populaire de Chine] ; DIHAN ZHOU [République populaire de Chine] ; YAOQING CHEN [République populaire de Chine] ; WEI HONG [République populaire de Chine] ; LUYANG CAO [République populaire de Chine] ; JINGYI YANG [République populaire de Chine] ; YAN ZHANG [République populaire de Chine] ; WEI SHI [République populaire de Chine] ; ZHIJIAN CAO [République populaire de Chine] ; YINGLIANG WU [République populaire de Chine] ; HUIMIN YAN [République populaire de Chine] ; WENXIN LI [République populaire de Chine] | Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses |
| 000074 |
KAI ZHAO [République populaire de Chine] ; HUI WANG [République populaire de Chine] ; CHANGYOU WU [République populaire de Chine] | The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8+ T cells are augmented in varying degrees by CpG ODN, Polyl:C and R848 |
| 000085 |
Lili Zhu [Allemagne] ; Shyla George [Allemagne] ; Marco F. Schmidt [Allemagne] ; Samer I. Al-Gharabli [Jordanie] ; Jörg Rademann [Allemagne] ; Rolf Hilgenfeld [Allemagne, République populaire de Chine] | Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease |
| 000130 |
XIANFENG LI [États-Unis] ; Yong-Kang Zhang [États-Unis] ; YANG LIU [États-Unis] ; Charles Z. Ding [États-Unis] ; QUN LI [États-Unis] ; Yasheen Zhou [États-Unis] ; Jacob J. Plattner [États-Unis] ; Stephen J. Baker [États-Unis] ; XUELEI QIAN [États-Unis] ; DAZHONG FAN [États-Unis] ; LIANG LIAO [États-Unis] ; Zhi-Jie Ni [États-Unis] ; Gemma V. White [Royaume-Uni] ; Jackie E. Mordaunt [Royaume-Uni] ; Linos X. Lazarides [Royaume-Uni] ; Martin J. Slater [Royaume-Uni] ; Richard L. Jarvest [Royaume-Uni] ; Pia Thommes [Royaume-Uni] ; Malcolm Ellis [Royaume-Uni] ; Colin M. Edge [Royaume-Uni] ; Julia A. Hubbard [Royaume-Uni] ; Don Somers [Royaume-Uni] ; Paul Rowland [Royaume-Uni] ; Pamela Nassau [Royaume-Uni] ; Bill Mcdowell [Royaume-Uni] ; Tadeusz J. Skarzynski [Royaume-Uni] ; Wieslaw M. Kazmierski [États-Unis] ; Richard M. Grimes [États-Unis] ; Lois L. Wright [États-Unis] ; Gary K. Smith [États-Unis] ; WUXIN ZOU [République populaire de Chine] ; Jon Wright [République populaire de Chine] ; Lewis E. Pennicott [Royaume-Uni] | Synthesis and evaluation of novel α-amino cyclic boronates as inhibitors of HCV NS3 protease |
| 000139 |
JUN LIU [République populaire de Chine] ; PENG WU [République populaire de Chine] ; FENG GAO [République populaire de Chine] ; JIANXUN QI [République populaire de Chine] ; Ai Kawana-Tachikawa [Japon] ; JING XIE [République populaire de Chine] ; Christopher J. Vavricka [République populaire de Chine] ; Aikichi Iwamoto [Japon] ; TAISHENG LI [République populaire de Chine] ; George F. Gao [République populaire de Chine] | Novel Immunodominant Peptide Presentation Strategy: a Featured HLA-A* 2402-Restricted Cytotoxic T-Lymphocyte Epitope Stabilized by Intrachain Hydrogen Bonds from Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein |
| 000180 |
Satoshi Ohno [Japon] ; Shunsuke Kohyama [Japon] ; Maiko Taneichi [Japon] ; Osamu Moriya [Japon] ; Hidenori Hayashi [Japon] ; Hiroshi Oda [Japon] ; Masahito Mori [Japon] ; Akiharu Kobayashi [Japon] ; Toshitalca Akatsuka [Japon] ; Tetsuya Uchida [Japon] ; Masanori Matsui [Japon] | Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice |
| 000201 |
Thomas Regnier [Japon] ; Diganta Sarma [Japon] ; Koushi Hidaka [Japon] ; Usman Bacha [États-Unis] ; Ernesto Freire [États-Unis] ; Yoshio Hayashi [Japon] ; Yoshiaki Kiso [Japon] | New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors |
| 000210 |
I-Jung Liu [Taïwan] ; Chuan-Liang Kao [Taïwan] ; Szu-Chia Hsieh [Taïwan] ; Ming-Tsair Wey [Taïwan] ; Lon-Sing Kan [Taïwan] ; Wei-Kung Wang [Taïwan] | Identification of a minimal peptide derived from heptad repeat (HR) 2 of spike protein of SARS-CoV and combination of HR1-derived peptides as fusion inhibitors |
| 000224 |
Ikenna G. Madu [États-Unis] ; Shoshannah L. Roth [États-Unis] ; Sandrine Belouzard [États-Unis] ; Gary R. Whittaker [États-Unis] | Characterization of a Highly Conserved Domain within the Severe Acute Respiratory Syndrome Coronavirus Spike Protein S2 Domain with Characteristics of a Viral Fusion Peptide |
| 000259 |
LANYING DU [Hong Kong, États-Unis] ; GUANGYU ZHAO [République populaire de Chine] ; YONGPING LIN [Hong Kong] ; CHRIS CHAN [Hong Kong] ; YUXIAN HE [États-Unis] ; SHIBO JIANG [États-Unis] ; CHANGYOU WU [République populaire de Chine] ; Dong-Yan Jin [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] ; YUSEN ZHOU [République populaire de Chine] ; Bo-Jian Zheng [Hong Kong] | Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection |
| 000284 |
Kenichi Akaji [Japon] ; Hiroyuki Konno [Japon] ; Mari Onozuka [Japon] ; Ayumi Makino [Japon] ; Hiroyuki Saito [Japon] ; Kazuto Nosaka [Japon] | Evaluation of peptide-aldehyde inhibitors using R188I mutant of SARS 3CL protease as a proteolysis-resistant mutant |
| 000290 |
Yi-Ming Shao [Taïwan] ; Wen-Bin Yang [Taïwan] ; Tun-Hsun Kuo [Taïwan] ; Keng-Chang Tsai [Taïwan] ; Chun-Hung Lin [Taïwan] ; An-Suei Yang [Taïwan] ; Po-Huang Liang [Taïwan] ; Chi-Huey Wong [Taïwan, États-Unis] | Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease |
| 000390 |
JIANMIN ZHANG [Canada] ; Hanna I. Pettersson [Canada] ; Carly Huitema [Canada] ; CHUNYING NIU [Canada] ; JIANG YIN [Canada] ; Michael N. G. James [Canada] ; Lindsay D. Eltis [Canada] ; John C. Vederas [Canada] | Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters |
| 000424 |
Syaulan Yang [Taïwan] ; Shu-Jen Chen [Taïwan] ; Min-Feng Hsu [Taïwan] ; Jen-Dar Wu [Taïwan] ; Chien-Te K. Tseng [États-Unis] ; Yu-Fan Liu [Taïwan] ; Hua-Chien Chen [Taïwan] ; Chun-Wei Kuo [Taïwan] ; Chi-Shen Wu [Taïwan] ; Li-Wen Chang [Taïwan] ; Wen-Chang Chen [Taïwan] ; Shao-Ying Liao [Taïwan] ; Teng-Yuan Chang [Taïwan] ; Hsin-Hui Hung [Taïwan] ; Hui-Lin Shr [Taïwan] ; Cheng-Yuan Liu [Taïwan] ; Yu-An Huang [Taïwan] ; Ling-Yin Chang [Taïwan] ; Jen-Chi Hsu [Taïwan] ; Clarence J. Peters [États-Unis] ; Andrew H.-J. Wang [Taïwan] ; Ming-Chu Hsu [Taïwan] | Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor |
| 000441 |
Kuo-Chen Chou [États-Unis, République populaire de Chine] ; Dong-Qing Wei [États-Unis, République populaire de Chine] ; Qi-Shi Du [États-Unis, République populaire de Chine] ; Suzanne Sirois [États-Unis, Canada] ; Wei-Zhu Zhong [États-Unis] | Progress in computational approach to drug development against SARS |
| 000491 |
Han-Zhong Zhang [États-Unis] ; HONG ZHANG [États-Unis] ; William Kemnitzer [États-Unis] ; Ben Tseng [États-Unis] ; Jindrich Jr Cinatl [Allemagne] ; Martin Michaelis [Allemagne] ; Hans Wilhelm Doerr [Allemagne] ; SUI XIONG CAI [États-Unis] | Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors |
| 000492 |
Tin-Yun Ho [Taïwan] ; Shih-Lu Wu [Taïwan] ; Jaw-Chyun Chen [Taïwan] ; Yen-Chiao Wei [Taïwan] ; Shin-Ei Cheng [Taïwan] ; Yung-Hsien Chang [Taïwan] ; Hsu-Jan Liu [Taïwan] ; Chien-Yun Hsiang [Taïwan] | Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction |
| 000504 |
Yu-Shan Wu [Taïwan] ; Wen-Hsing Lin [Taïwan] ; John T.-A. Hsu [Taïwan] ; Hsing-Pang Flsieh [Taïwan] | Antiviral drug discovery against SARS-CoV |
| 000536 |
Angus J. Macdonald [États-Unis] ; LONG CAO [États-Unis] ; YUXIAN HE [États-Unis] ; QIAN ZHAO [États-Unis] ; SHIBO JIANG [États-Unis] ; Sara Lustigman [États-Unis] | rOv-ASP-1, a recombinant secreted protein of the helminth onchocerca volvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens |
| 000558 |
Bo-Jian Zheng [Hong Kong] ; YI GUAN [Hong Kong] ; Ming-Liang He [Hong Kong] ; HONGZHE SUN [Hong Kong] ; LANYING DU [Hong Kong] ; YING ZHENG [Hong Kong] ; Kin-Ling Wong [Hong Kong] ; HONGLIN CHEN [Hong Kong] ; YING CHEN [Hong Kong] ; LINYU LU [Hong Kong] ; Julian A. Tanner [Hong Kong] ; Rory M. Watt [Hong Kong] ; Neri Niccolai [Italie] ; Andrea Bernini [Italie] ; Ottavia Spiga [Italie] ; Patrick C. Y. Woo [Hong Kong] ; Hsiang-Fu Kung [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] ; Jian-Dong Huang [Hong Kong] | Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus |
| 000581 |
Erika Martina [Allemagne] ; Nikolaus Stiefl [Allemagne] ; Björn Degel [Allemagne] ; Franziska Schulz [Allemagne] ; Alexander Breuning [Allemagne] ; Markus Schiller [Allemagne] ; Radim Vicik [Allemagne] ; Knut Baumann [Allemagne] ; John Ziebuhr [Allemagne] ; Tanja Schirmeister [Allemagne] | Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor |
| 000632 |
Jaime Guillen [Espagne] ; Ana J. Perez-Berna [Espagne] ; Miguel R. Moreno [Espagne] ; José Villalain [Espagne] | Identification of the membrane-active regions of the severe acute respiratory syndrome coronavirus spike membrane glycoprotein using a 16/18-mer peptide scan: Implications for the viral fusion mechanism |
| 000638 |
Bruno Jr Sainz [États-Unis] ; Joshua M. Rausch [États-Unis] ; William R. Gallaher [États-Unis] ; Robert F. Garry [États-Unis] ; William C. Wimley [États-Unis] | Identification and characterization of the putative fusion peptide of the severe acute respiratory syndrome-associated coronavirus spike protein |
| 000663 |
Jiun-Jie Shie [Taïwan] ; Jim-Min Fang [Taïwan] ; Chih-Jung Kuo [Taïwan] ; Tun-Hsun Kuo [Taïwan] ; Po-Huang Liang [Taïwan] ; Hung-Jyun Huang [Taïwan] ; Wen-Bin Yang [Taïwan] ; Chun-Hung Lin [Taïwan] ; Jiun-Ling Chen [Taïwan] ; Yin-Ta Wu [Taïwan] ; Chi-Huey Wong [Taïwan, États-Unis] | Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease |
| 000757 |
Wai-Yan Choy [Hong Kong] ; Shu-Guang Lin [République populaire de Chine] ; Paul Kay-Sheung Chan [Hong Kong] ; John Siu-Lun Tam [Hong Kong] ; Y. M. Dennis Lo [Hong Kong] ; Ida Miu-Ting Chu [Hong Kong] ; Sau-Na Tsai [Hong Kong] ; Ming-Qi Zhong [Hong Kong] ; Kwok-Pui Fung [Hong Kong] ; Mary Miu-Yee Waye [Hong Kong] ; Stephen Kwok-Wing Tsui [Hong Kong] ; Kai-On Ng [Hong Kong] ; Zhi-Xin Shan [République populaire de Chine] ; MIN YANG [République populaire de Chine] ; Yi-Long Wu [République populaire de Chine] ; Zhan-Yi Lin [République populaire de Chine] ; Sai-Ming Ngai [Hong Kong] | Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: Perspective for SARS vaccine development |
| 000758 |
Rajendra P. Jain [Canada] ; Hanna I. Pettersson ; JIANMIN ZHANG ; Katherine D. Aull ; Pascal D. Fortin ; Carly Huitema ; Lindsay D. Eltis ; Jonathan C. Parrish ; Michael N. G. James ; David S. Wishart ; John C. Vederas | Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro |
| 000853 |
Paul K. S. Chan [Hong Kong] ; W. K. To [Hong Kong] ; Esther Y. M. Liu [Hong Kong] ; T. K. Ng [Hong Kong] ; John S. Tam [Hong Kong] ; Joseph J. Y. Sung [Hong Kong] ; Jean-Michel Lacroix [Canada] ; Michel Houde [Canada] | Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody |
| 000856 |
I-Ju Liu [Taïwan] ; Po-Ren Hsueh [Taïwan] ; Chin-Tarng Lin [Taïwan] ; Chien-Yu Chiu [Taïwan] ; Chuan-Liang Kao [Taïwan] ; Mei-Ying Liao [Taïwan] ; Han-Chung Wu [Taïwan] | Disease-specific B cell epitopes for serum antibodies from patients with severe acute respiratory syndrome (SARS) and serologic detection of SARS antibodies by epitope-based peptide antigens |
| 000992 |
D. J. Van Den Heuvel [Pays-Bas] ; R. P. H. Kooyman [Pays-Bas] ; J. W. Drijfhout ; G. W. Welling | Synthetic peptides as receptors in affinity sensors : a feasibility study |
